Final research reports made available on this website
Third parties have prepared final research reports for Pork CRC Ltd ACN 150 210 325 (Pork CRC), summarising the methodology, outcomes and potential applications of research projects that have been conducted via Pork CRC (Research Reports).
Those Research Reports are provided “as is” for the purpose of disseminating information to the public.
Any views, standards or recommendations expressed in those Research Reports do not necessarily reflect the position of Pork CRC. To the maximum extent permitted by law, and unless expressly stated otherwise, Pork CRC:
- makes no representation or warranty about the accuracy, reliability, currency, completeness or lawfulness of any Research Reports;
- does not exercise any editorial control or supervision over such Research Reports;
- cannot and does not endorse the content of any Research Reports; and
- suggests that users of the Research Reports exercise their own independent skill and judgment before relying on the content of any Research Reports and, where necessary or appropriate, seek independent professional advice which is relevant to their individual circumstances.
By continuing to use the Research Reports, and to the maximum extent permitted by law, you:
- accept the abovementioned terms upon which Research Reports are made available to you; and
- release Pork CRC and each of its officers, employees and agents from any claims or losses that you may suffer or incur in reliance upon or use of those Research Reports.
SubProgram 2A – Novel Disease Diagnostics
2A-101: Validation of data collection program for antibiotic use – Pat Mitchell, Rivalea – Confidential
2A-111: An investigation into the extent of occurrence of novel pathogenic Brachyspira species, including newly recognised agents of swine dysentery, in Australian pig herds – Dave Hampson, Murdoch University – Summary Report
2A-114: Identifying, tracking and controlling swine dysentery in Australian pig herds – Dave Hampson, Murdoch University – Confidential
SubProgram 2B – Healthy, Robust Pig Genotypes
SubProgram 2C – Replacement of Antibiotics with Effective Integrated Health Strategies
2C-102: Strategies to quantitatively measure and reduce the load of Lawsonia in commercial herds – Alison Collins, NSW DPI – Summary Report Confidential
2C-103: Evaluating the efficacy of a Live APP vaccine with and without bacterin vaccines – Hugo Dunlop, Chris Richards & Associates – Cancelled
2C-105: Use of plant derived compounds to reduce post weaning antibiotic use – Eugeni Roura, University of Queensland Summary Report Confidential
2C-110: Dietary manipulation of the pro-inflammatory cascade to minimise impacts on production and health indices in weaner pigs experimentally infected with an enterotoxigenic strain of E. coli – Jae Kim, DAFWA – Summary Report
2C-113: Bacteriophage-displayed peptides for the control of pathogens in swine – Sharon Bishop-Hurley, CSIRO – Summary Report Confidential
2C-114: High fibre diets and impact on gut health – John Pluske, Murdoch University – Confidential
2C-116: Live attenuated Actinobacillus pleuropneumoniae vaccine strains – Conni Turni, University of Queensland Summary Report Confidential
2C-117: Aerosol disinfection for control of APP15 – Peter McKenzie, Rivalea Report
2C-119: Alternative to vitamin E for the cost-effective maintenance of cellular antioxidant capacity in weaner pigs experimentally infected with enterotoxigenic strain of E. coli. – Jae Kim, DAFWA – Summary Report
2C-121: A novel and safe fogging sanitiser for MRSA decolonisation and reduction of Actinobacillus pleuropneumoniae aerosol transmission between pigs. – Darren Trott, University of Adelaide – Summary – Report
2C-122: Alternatives to antibiotics for diarrhoea control, improved production and maintenance of intestinal health in weaner pigs – Alison Collins, NSW DPI – Confidential
2C-123: Self-assembled peptides as antimicrobial nanomaterials – Sharon Bishop-Hurley, CSIRO – Summary Report Confidential
2C-124: Evaluation of an atypical Brachyspira hyodysenteriae strain as a live vaccine to control swine dysentery – David Hampson, Murdoch University – Confidential
2C-126: Utilization of next generation sequencing for identifying Streptococcus suis clones responsible for recurrent outbreaks and identifying effective S. suis autogenous vaccine candidates. – Sam Abraham – Murdoch University – Summary – Report
2C-128: Protection from Escherichia coli-associated diseases after weaning in pigs using xenogeneic polyclonal antibodies specific for Escherichia coli fimbriae. – Cassandra Berry, Murdoch University – Confidential